El Monte-based genetic testing and analysis company Fulgent Genetics Inc., which rode the Covid testing wave, is moving ahead with its post-Covid strategy.
Testing offers CBR families the opportunity to proactively seek additional information about their child s health
TRUMBULL, Conn. and EL MONTE, Calif., Feb. 9, 2024 /PRNewswire/ .
For El Monte-based clinical diagnostic testing company Fulgent Genetics Inc., the Covid testing surge that catapulted the company from $32 million in annual revenue to the doorstep of $1 billion in just two years has now all but ended.
Operator: Hello and welcome to the Fulgent Genetics Q1 2023 Earnings Conference Call and Webcast. [Operator Instructions] As a reminder, this conference is being recorded.
Operator: Hello and welcome to the Fulgent Genetics Q4 and Fiscal Year 2022 Earnings Conference Call and Webcast. As a reminder, this conference is being recorded.